CN

News

Size: LMS

Shen Lianzhong, Director of Shandong Xinbo Security Evaluation Center, delivered an excellent report at the 7th Senior Training Course for Special Leaders

2024/10/28

On August 24-25, 2024, the "7th Advanced Training Course for Non Clinical Safety Evaluation of Drugs" was held in Qingdao, Shandong Province. Shen Lianzhong, Director of the Drug Safety Evaluation Research Center of Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo Safety Evaluation Center"), brings a wonderful report on the theme of "Comprehensive Management and Optimization of GLP Laboratory Informatization - Application and Focus of Data Collection System".


Shen Lianzhong

On August 24-25, 2024, the "7th Advanced Training Course for Non Clinical Safety Evaluation of Drugs" was held in Qingdao, Shandong Province. Shen Lianzhong, Director of the Drug Safety Evaluation Research Center of Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo Safety Evaluation Center"), brings a wonderful report on the theme of "Comprehensive Management and Optimization of GLP Laboratory Informatization - Application and Focus of Data Collection System".


  学术报告回顾  
Director Shen reported on the advantages of LIMS application, preparation before application, performance verification, focus points during the implementation of the project, and potential risks of application. Especially during the implementation of the special topic, attention should be paid to the laboratory labeling system, individual animal identification and numbering, storage and use of test substances, preparation of test substances, and observation of clinical symptoms in animals.



The currently independently developed STSS (Standard Toxicity Study System) system includes modules such as organizational management, instruments and equipment, test substances, reagents, SOP, environmental monitoring, QAU, thematic implementation (general toxicity, reproductive toxicity), form printing, and message sprites. At present, the system has entered the comprehensive testing phase and is expected to enter full application by the end of 2024.

Participants of Shandong Xinbo Pharmaceutical Research Co., Ltd. took a group photo to commemorate the occasion


Did you find the information you needed?

Great, thank you for your feedback.
Thank you for your feedback.